Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products
HONG KONG, Aug 11, 2025 – (ACN Newswire via SeaPRwire.com) – Cryofocus Medtech (Shanghai) Co., Ltd. (“Cryofocus” or the “Company,” Stock Code: 6922.HK), a global innovator in minimally invasive interventional cryotherapy, last friday announced its unaudited interim results for the six months ended June 30, 2025. The Company demonstrated robust growth momentum and significant operational […]